Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Padmanee Sharma, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Florida, and Oklahoma. She is a Professor at Division of.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2004
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2000
Pennsylvania State University College of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2004 - 2026
OK State Medical License 2020 - 2021
NY State Medical License 1999 - 2005
Publications & Presentations
PubMed
- 1 citationsImmune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective ...Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, Daniel D Shapiro, Jose A Karam
Nature Communications. 2025-02-21 - 7 citationsNext-generation combination approaches for immune checkpoint therapy.Sangeeta Goswami, Kristen E Pauken, Linghua Wang, Padmanee Sharma
Nature Immunology. 2024-12-01 - Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cel...Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, Daniel D Shapiro, Jose A Karam
Research Square. 2024-11-12
Press Mentions
NEUVOGEN Appoints James P. Allison, Ph.D. And Padmanee Sharma, M.D., Ph.D to Its Scientific Advisory BoardApril 16th, 2025- MD Anderson Unveils Key Research Breakthroughs: Highlights from March 12, 2025March 12th, 2025
- MD Anderson Research Highlights for March 12, 2025March 12th, 2025
- Join now to see all
Grant Support
- Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)UNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
